Identification of anti-TIM-3 based checkpoint inhibitor combinations with activity in immunotherapy refractory melanoma models. - Phadke MS; Li J; Sriramareddy S; Rodriguez PC; Ruffell B; Luca VC; Tran TTT; Chen YA; Smalley KSM (Journal for immunotherapy of cancer, 2025)